Azenta, Inc. (NASDAQ:AZTA) Expected to Post Quarterly Sales of $141.73 Million

Equities research analysts expect Azenta, Inc. (NASDAQ:AZTAGet Rating) to report sales of $141.73 million for the current quarter, Zacks reports. Three analysts have issued estimates for Azenta’s earnings, with the highest sales estimate coming in at $142.60 million and the lowest estimate coming in at $140.58 million. Azenta posted sales of $286.59 million in the same quarter last year, which suggests a negative year-over-year growth rate of 50.5%. The business is scheduled to issue its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Azenta will report full year sales of $588.62 million for the current financial year, with estimates ranging from $587.70 million to $589.40 million. For the next year, analysts anticipate that the business will post sales of $687.47 million, with estimates ranging from $684.94 million to $690.00 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Azenta.

Azenta (NASDAQ:AZTAGet Rating) last issued its quarterly earnings data on Tuesday, February 8th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.04. The firm had revenue of $139.65 million during the quarter, compared to the consensus estimate of $135.34 million. Azenta had a return on equity of 8.87% and a net margin of 14.57%. The company’s quarterly revenue was up 18.2% on a year-over-year basis. During the same period last year, the company earned $0.47 EPS.

Several equities analysts have weighed in on AZTA shares. B. Riley started coverage on Azenta in a research report on Thursday, March 31st. They issued a “buy” rating for the company. Evercore ISI started coverage on Azenta in a research report on Monday, March 21st. They issued an “outperform” rating and a $100.00 target price for the company. Zacks Investment Research raised Azenta from a “sell” rating to a “hold” rating in a research report on Wednesday, April 27th. Finally, Needham & Company LLC decreased their price objective on Azenta from $155.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, February 9th.

NASDAQ AZTA opened at $74.96 on Monday. The firm has a market cap of $5.62 billion, a P/E ratio of 43.58 and a beta of 1.69. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.13 and a current ratio of 2.33. The firm has a 50-day moving average price of $82.05. Azenta has a 1-year low of $71.19 and a 1-year high of $124.79.

Azenta Company Profile (Get Rating)

Azenta, Inc provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates.

Featured Articles

Get a free copy of the Zacks research report on Azenta (AZTA)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with's FREE daily email newsletter.